AFT Pharmaceuticals Company Description

AFT Pharmaceuticals Limited, together with its subsidiaries, develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally.

The company offers patented, branded, and generic drugs; and products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, pain management, skin care, vitamins, supplements, gastrointestinal, dermatology, and hospital.

It has a research and development collaboration with Belgium’s Hyloris Pharmaceuticals to develop a novel innovative injectable iron deficiency therapy.

AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.

AFT Pharmaceuticals Limited

Country	New Zealand
Founded	1997
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	119
CEO	Hartley Atkinson

Contact Details

Address: 129 Hurstmere Road Auckland, 0622 New Zealand
Phone	64 8 0042 3823
Website	aftpharm.com

Stock Details

Ticker Symbol	AFP
Exchange	Australian Securities Exchange
Fiscal Year	April - March
Reporting Currency	NZD
ISIN Number	NZAFTE0001S4
SIC Code	2834

Key Executives

Name	Position
Dr. Hartley Atkinson Ph.D.	Co-Founder, Chief Executive Officer, MD and Executive Director
Marree Atkinson	Co-Founder, Chief of Staff and Executive Director
Malcolm Tubby B.A., BA(Hon's), ICAEW, ICANZ	Chief Financial Officer and Company Secretary
Ioana Stanescu	Chief Scientific Officer
Murray Keith	Group Marketing Manager